Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Pharma
Opdivo-maker Ono pays $2.4B for Deciphera
The price tag includes both the approved cancer drug Qinlock and another Deciphera candidate heading to the FDA’s desk in the coming months.
James Waldron
Apr 29, 2024 8:55am
Is AstraZeneca stretching too thin with M&As? CEO says 'no'
Apr 25, 2024 11:09am
Sponsored
MAIC Methodology Matters: Comparing BRUKINSA vs Acalabrutinib in R/R CLL
Apr 1, 2024 8:00am
Regulatory tracker: Carvykti scores EC's 2L myeloma nod
Apr 22, 2024 11:35am
Roche touts near-complete MS suppression for injectable Ocrevus
Apr 17, 2024 11:00am
Intra-Cellular moves closer to Caplyta depression expansion
Apr 16, 2024 2:27pm